A phase 3, randomized, double-blind, active-controlled trial evaluating efficacy and safety of avatrombopag versus eltrombopag in ITP. uri icon

Overview

publication date

  • June 20, 2023

Identity

Digital Object Identifier (DOI)

  • 10.1111/bjh.18908

PubMed ID

  • 37339869